| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.02B | $1.80B | $1.68B |
| YoY Revenue Growth % | +11.9% | +7.4% | — |
| Gross Profit | $635.9M | $556.3M | — |
| Gross Margin % | 31.5% | 30.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $176.9M | $145.4M | $138.7M |
| Operating Margin % | 8.8% | 8.1% | 8.3% |
| Net Income (GAAP) | $88.7M | $70.5M | $68.8M |
| EBITDA (Normalized) | $209.1M | $165.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $94.3M | $102.2M | $106.2M |
| Capital Expenditures (CapEx) | $40.3M | $25.1M | — |
| Free Cash Flow (FCF) | $54.0M | $77.1M | $106.2M |
| FCF Margin % | 2.7% | 4.3% | 6.3% |
| Return on Invested Capital (ROIC %) | 13.8% | 12.8% | — |
| Cash & Short-Term Equivalents | $303.8M | $148.3M | — |
| Total Debt (Short + Long Term) | $818.5M | $621.7M | — |
| Total Stockholders' Equity | $498.4M | $422.8M | — |